Micar Innovation (Micar21) Alternatives & Competitors

12 companies similar to Micar Innovation (Micar21) — Micar Innovation - Drug Discovery Factory for novel drug molecules (structure ba...

Biognosys

Transforming life sciences with cutting-edge proteomics technology and solutions

90 Series G $9.03M

Schlieren, Switzerland

Biotechnology Health Care

Recursion

Decoding Biology to Radically Improve Lives

770 IPO $1.30B

Salt Lake City, United St...

AI Biotechnology +3

Peptris Technologies

AI plays tetris with proteins

11 Pre-Seed $1.00M

Bengaluru, India

AI Biotechnology

Amyl Therapeutics

Restoring clarity in amyloid diseases

11 Grant $29.70M

Liege, Belgium

Biotechnology Health Care +1

Track all Micar Innovation (Micar21) competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

iktos

Artificial intelligence for new drug design

85 Series A $18.90M

Paris, France

AI Biotechnology +2

Dicerna Pharmaceuticals

Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...

201-500 Post-IPO Equity $420.45M

Biotechnology Health Care +1

Xcene Research

Finding Innovative Global Health Solutions For Today and Tomorrow Through Clinical Researc...

110

Ikeja, Nigeria

Biotechnology Health Care +1

InVivoCloud - AI Platform

An innovative approach to long-term research on rodent behavior

San Diego, United States

AI Big Data +1

aTyr Pharma

aTyr is a biotherapeutics company engaged in the development of innovative medicines based...

79 Post-IPO Equity $402.50M

San Diego, United States

Biotechnology Health and Wellness +1

Onena Medicines

AI-centric preclinical company discovering and developing novel biopharmaceuticals to trea...

9 $3.73M

Basel, Switzerland

Biotechnology Health Care +1

Cantabio Pharmaceuticals, Inc.

Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...

13 Grant

Sunnyvale, United States

Biotechnology Pharmaceutical

Dewpoint Therapeutics

Translating condensate biology into medicine.

57 Series C $287.00M

Boston, United States

Biotechnology Health Care +2

About Micar Innovation (Micar21)

Micar Innovation (Micar21) is a pioneering drug discovery factory, utilizing in silico drug design and AI to create novel drug molecules for various diseases such as neuroscience, oncology, cardio-vascularity, dermatology, and rare diseases. The company aims to enhance societal well-being by developing blockbuster drug...

Taxonomy

Drug Discovery, Innovation, Pharmaceuticals, AI In Drug Design, Preclinical Research, Neuroscience, Oncology, Cardiovascular Research, Rare Diseases, Intellectual Property, Biotech, Computer-Aided Drug Discovery, Market Analysis

Frequently Asked Questions

Companies similar to Micar Innovation (Micar21) include Biognosys, Recursion, Peptris Technologies, Amyl Therapeutics, iktos. They work in Biotechnology and Health Care and share Micar Innovation (Micar21)'s focus on drug discovery, rare diseases and oncology.

Bounce Watch lists 12 companies that share Micar Innovation (Micar21)'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Micar Innovation (Micar21) and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Micar Innovation (Micar21) Profile Biognosys Alternatives Recursion Alternatives Peptris Technologies Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Micar Innovation (Micar21) on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.